Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approachReview Published on 2012-07-192024-09-04 Journal: Drug Design, Development and Therapy [Category] 대상포진, [키워드] fingolimod FTY720 multiple sclerosis oral compounds Patient satisfaction phosphate sphingosine 1 [DOI] 10.2147/DDDT.S8927 PMC 바로가기 [Article Type] Review